InterCure Ltd. (TLV:INCR)

InterCure Statistics

Total Valuation

InterCure has a market cap or net worth of ILS 138.67 million. The enterprise value is 270.58 million.

Market Cap	138.67M
Enterprise Value	270.58M

Important Dates

The last earnings date was Friday, May 15, 2026.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

InterCure has 54.68 million shares outstanding. The number of shares has increased by 18.12% in one year.

Current Share Class	54.68M
Shares Outstanding	54.68M
Shares Change (YoY)	+18.12%
Shares Change (QoQ)	+29.17%
Owned by Insiders (%)	26.19%
Owned by Institutions (%)	2.49%
Float	37.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.51
PB Ratio	0.35
P/TBV Ratio	0.78
P/FCF Ratio	10.43
P/OCF Ratio	8.23
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.58
EV / Sales	1.00
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	20.36

Financial Position

The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.45.

Current Ratio	1.48
Quick Ratio	0.96
Debt / Equity	0.45
Debt / EBITDA	n/a
Debt / FCF	13.45
Interest Coverage	-1.28

Financial Efficiency

Return on equity (ROE) is -9.27% and return on invested capital (ROIC) is -4.83%.

Return on Equity (ROE)	-9.27%
Return on Assets (ROA)	-2.19%
Return on Invested Capital (ROIC)	-4.83%
Return on Capital Employed (ROCE)	-5.36%
Weighted Average Cost of Capital (WACC)	7.61%
Revenue Per Employee	844,375
Profits Per Employee	-111,594
Employee Count	320
Asset Turnover	0.37
Inventory Turnover	2.01

Taxes

Income Tax	-7.32M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.87% in the last 52 weeks. The beta is 0.33, so InterCure's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	-54.87%
50-Day Moving Average	247.69
200-Day Moving Average	386.62
Relative Strength Index (RSI)	52.87
Average Volume (20 Days)	66,850

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, InterCure had revenue of ILS 270.20 million and -35.71 million in losses. Loss per share was -0.66.

Revenue	270.20M
Gross Profit	40.70M
Operating Income	-25.51M
Pretax Income	-44.10M
Net Income	-35.71M
EBITDA	-8.36M
EBIT	-25.51M
Loss Per Share	-0.66

Balance Sheet

The company has 46.68 million in cash and 178.75 million in debt, with a net cash position of -132.08 million or -2.42 per share.

Cash & Cash Equivalents	46.68M
Total Debt	178.75M
Net Cash	-132.08M
Net Cash Per Share	-2.42
Equity (Book Value)	396.36M
Book Value Per Share	7.71
Working Capital	102.38M

Cash Flow

In the last 12 months, operating cash flow was 16.84 million and capital expenditures -3.55 million, giving a free cash flow of 13.29 million.

Operating Cash Flow	16.84M
Capital Expenditures	-3.55M
Depreciation & Amortization	17.15M
Net Borrowing	-29.13M
Free Cash Flow	13.29M
FCF Per Share	0.24

Margins

Gross margin is 15.06%, with operating and profit margins of -9.44% and -13.22%.

Gross Margin	15.06%
Operating Margin	-9.44%
Pretax Margin	-16.32%
Profit Margin	-13.22%
EBITDA Margin	-3.10%
EBIT Margin	-9.44%
FCF Margin	4.92%

Dividends & Yields

InterCure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.12%
Shareholder Yield	-18.12%
Earnings Yield	-25.75%
FCF Yield	9.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 8, 2021. It was a reverse split with a ratio of 0.2247564764.

Last Split Date	Apr 8, 2021
Split Type	Reverse
Split Ratio	0.2247564764

Scores

Altman Z-Score	n/a
Piotroski F-Score	4